Journal article

Desvenlafaxine in the treatment of major depression: an updated overview

Trevor R Norman, James S Olver

EXPERT OPINION ON PHARMACOTHERAPY | TAYLOR & FRANCIS LTD | Published : 2021

Abstract

Introduction: Major depressive disorder (MDD) remains one of the most prevalent mental health conditions. It is a chronic, relapsing condition and despite multiple treatment options, many patients fail to achieve remission of symptoms. Inadequacy of treatment has stimulated the search for agents with significant therapeutic advantages.Areas covered: This review examines literature concerning the use of desvenlafaxine in the treatment of MDD published since a previous analysis in this journal in 2014. Published papers were identified via a PubMed and Web of Science search and excluded congress presentations. Results from clinical trials in MDD, systematic reviews, and post hoc analyses in pat..

View full abstract